Recent Updates
Recently added Catalysts
ABT

Abbott Announces CE Mark for i-STAT Alinity, a Pioneering, Handheld Blood Testing Platform Abbott (NYSE: ABT) announced today its i-STAT® Alinity™ System, an innovative, handheld blood testing platform, received CE Mark and is now for sale...

Key Takeaway: To address these needs, Abbott developed i-STAT Alinity to be intelligent, intuitive and easy to use, empowering healthcare professionals to provide high-quality care for people across the globe. First-of-its kind, patented features include: In today's pressure-packed healthcare

Full Press Release Details

To address these needs, Abbott developed i-STAT Alinity to be intelligent, intuitive and easy to use, empowering healthcare professionals to provide high-quality care for people across the globe. First-of-its kind, patented features include:
In today's pressure-packed healthcare environment, clinicians rely on easy-to-use testing technologies that do not require complex training. Innovative point of care testing tools like Abbott's i-STAT Alinity can help address this need and provide a simpler experience for those who use it, allowing them to accurately diagnose and treat patients faster and more efficiently.
DESIGNED WITH CUSTOMER-DRIVEN INSIGHTS To better understand customer needs, Abbott sent cross-functional teams to visit administrators, clinicians and laboratory professionals to gain specific insights on the experiences and challenges healthcare providers face day-to-day with point of care testing.
i-STAT Alinity is the first of several next-generation instruments Abbott will launch as part of its harmonized family of Alinity systems across point of care, immunoassay, clinical chemistry, hematology, blood and plasma screening and molecular diagnostics. To learn more about Abbott's i-STAT Alinity, visit www.abbott.com/newsroom/news.html . Healthcare providers can find more information at https://www.abbottpointofcare.com/i - stat - alinity - ce .
About Abbott: At Abbott, we're committed to helping you live your best possible life through the power of health. For more than 125 years, we've brought new products and technologies to the world—in nutrition, diagnostics, medical devices and branded generic pharmaceuticals—that create more possibilities for more people at all stages of life. Today, 74,000 of us are working to help people live not just longer, but better, in the more than 150 countries we serve.
Connect with us at www.abbott.com , on Facebook at www.facebook.com/Abbott and on Twitter @AbbottNews and @AbbottGlobal.
1 i-STAT Alinity is launching with a comprehensive test menu, including blood gases, chemistries, electrolytes and hematology. Commercial availability of cartridges may vary depending on geographic locations. Cardiac markers, coagulation and other tests will be available at a later date.

Related Links

21 %

Last updated: Nov 30, 2016